E-LIB Suche - Ergebnisse für: Weisel, Katja C

1

CD8+ CD28− regulatory T cells after induction therapy predi..:

Kriegsmann, Katharina ; Ton, Gigi Nu Hoang Quy ; Awwad, Mohamed H. S....
Leukemia. 38 (2024) 7 - p. 1621-1625 , 2024

Link: https://doi.org/10.1038/..

2

BCMA x CD3 T-cell engager in a patient with penta-refractor..:

Cords, Leon ; Schaefers, Christoph ; Kamili, Abdulaziz...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

3

Implications and prognostic impact of mass spectrometry in ..:

Mai, Elias K. ; Huhn, Stefanie ; Miah, Kaya...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

4

Daratumumab, Bortezomib, and Dexamethasone for Treatment of..:

Leypoldt, Lisa B. ; Gavriatopoulou, Maria ; Besemer, Britta...
Cancers. 15 (2023) 18 - p. 4667 , 2023

Link: https://doi.org/10.3390/..

5

Management of multiple myeloma-related renal impairment: re..:

Dimopoulos, Meletios A ; Merlini, Giampaolo ; Bridoux, Frank...
The Lancet Oncology. 24 (2023) 7 - p. e293-e311 , 2023

Link: https://doi.org/10.1016/..

6

Predictors of early morbidity and mortality in newly diagno..:

Mai, Elias K. ; Hielscher, Thomas ; Bertsch, Uta...
Leukemia. 38 (2023) 3 - p. 640-647 , 2023

Link: https://doi.org/10.1038/..

7

Rates of Influenza and Pneumococcal Vaccination and Correla..:

Thompson, Michael A. ; Boccadoro, Mario ; Leleu, Xavier...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) 3 - p. e171-e181 , 2023

Link: https://doi.org/10.1016/..

8

Risk factors for poor humoral response to primary and boost..:

Schönlein, Martin ; Wrage, Victoria ; Ghandili, Susanne...
Cancer Cell. 40 (2022) 6 - p. 581-583 , 2022

Link: https://doi.org/10.1016/..

9

Post-Vaccination Anti-SARS-CoV-2-Antibody Response in Patie..:

Ghandili, Susanne ; Schönlein, Martin ; Lütgehetmann, Marc...
Cancers. 13 (2021) 15 - p. 3800 , 2021

Link: https://doi.org/10.3390/..

10

Isatuximab, carfilzomib, lenalidomide, and dexamethasone (I..:

Leypoldt, Lisa B. ; Besemer, Britta ; Asemissen, Anne Marie...
Leukemia. 36 (2021) 3 - p. 885-888 , 2021

Link: https://doi.org/10.1038/..

11

Ixazomib-Lenalidomide-Dexamethasone in Routine Clinical Pra..:

Hájek, Roman ; Minařík, Jiří ; Straub, Jan...
Future Oncology. 17 (2021) 19 - p. 2499-2512 , 2021

Link: https://doi.org/10.2217/..

12

Management of patients with multiple myeloma beyond the cli..:

Terpos, Evangelos ; Mikhael, Joseph ; Hajek, Roman...
Blood Cancer Journal. 11 (2021) 2 - p. , 2021

Link: https://doi.org/10.1038/..

13

Lenalidomide versus bortezomib maintenance after frontline ..:

Baertsch, Marc-Andrea ; Mai, Elias K. ; Hielscher, Thomas...
Blood Cancer Journal. 11 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

14

Publisher Correction: Bortezomib-based induction, high-dose..:

Mai, Elias K. ; Miah, Kaya ; Bertsch, Uta...
Leukemia. 35 (2021) 12 - p. 3636-3636 , 2021

Link: https://doi.org/10.1038/..

15

Outcome of a Real-World Patient Cohort with Secondary CNS L..:

Thiele, Benjamin ; Binder, Mascha ; Schliffke, Simon...
Oncology Research and Treatment. 44 (2021) 7-8 - p. 375-381 , 2021

Link: https://doi.org/10.1159/..